4507:TYO
Shionogi & Co Ltd
¥3,025.00
arrow_upward
+0.43%(+13.00) 1D
Nov 2, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4507...
Open
¥3,082
High
¥3,106
Low
¥2,990
Mkt. cap
2.69T
Avg. vol.
3.25M
Volume
3.77M
Dividend
2.58%
Quarterly dividend
¥20
Ex-dividend date
Sep 29, 2026
P/E ratio
10.67
52-wk high
¥3,758
52-wk low
¥2,545
EPS
¥283
Shares outstanding
314.50M
No. of employees
6K
Open
¥3,082
High
¥3,106
Low
¥2,990
Mkt. cap
2.69T
Avg. vol.
3.25M
Volume
3.77M
Dividend
2.58%
Quarterly dividend
¥20
Ex-dividend date
Sep 29, 2026
P/E ratio
10.67
52-wk high
¥3,758
52-wk low
¥2,545
EPS
¥283
Shares outstanding
314.50M
No. of employees
6K
News stories
From web sources and news partners
BioSpectrum Asia
·
9 hours ago
Japan's Shionogi transfers generic drug business to Zhejiang Gaozhi Pharma in China
Profile
Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana.
Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines.
In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough to become a sole marketing agent for its products in Japan.
Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV.
The company is listed on the Tokyo Stock Exchange and Osaka Securities Exchange and is constituent of the Nikkei 225 stock index.
In June 2023, Shionogi announced its acquisition of Qpex Biopharma for approximately $140m.
On 5 October 2026, Shionogi announced an agreement to acquire IntraBio for US$2 billion through its US subsidiary, Shionogi Inc. Wikipedia
About Shionogi & Co Ltd
CEOIsao Teshirogi
Employees6.22K
FoundedJun 5, 1919
Headquarters-
SectorPharmaceutical industry
Websiteshionogi.com